KRRO
Korro Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.90
+6.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 215.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.41x
- Price / sales
- 104.45x
- Price / cash flow
- -3.66x
Enterprise value
- Enterprise value
- $176.0M
- EV / sales
- 73.87x
- EV / EBITDA
- -2.45x
- EV / EBIT
- -2.33x
- Market cap
- $248.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026